Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)
Titel:
Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)
Auteur:
Matikas, A. Kentepozidis, Ν. Ardavanis, A. Vaslamatzis, M. Polyzos, A. Emmanouilides, Ch. Katsaounis, P. Koinis, F. Xynogalos, S. Christopoulou, A. Ziras, N. Tegos, Th. Prinarakis, E. Hatzidaki, D. Georgoulias, V. Kotsakis, A.